[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100431626":3},{"organization":4,"outcomesModule":7,"designInfo":48,"detailedDescription":47,"studyPopulation":50,"armGroups":51,"interventions":57,"overallOfficials":62,"centralContacts":71,"locations":79,"responsibleParty":121,"collaborators":124,"id":127,"slug":47,"hasResults":128,"nctId":129,"briefTitle":130,"officialTitle":131,"acronym":47,"eligibilityCriteria":132,"healthyVolunteers":128,"sex":133,"minAge":134,"maxAge":47,"enrollmentInfo":135,"targetDuration":138,"studyType":139,"phases":47,"briefSummary":140,"conditions":141,"keywords":147,"overallStatus":82,"whyStopped":47,"lastUpdateSubmitDate":152,"lastUpdatePostDateStruct":153,"startDateStruct":156,"completionDateStruct":158,"leadSponsor":160,"locationsCount":161},{"fullName":5,"class":6},"University of Florence","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":19,"otherOutcomes":47},[9,13,16],{"measure":10,"description":11,"timeFrame":12},"Number of participants who will die from bladder cancer","Bladder Cancer Specific Mortality after surgery","From enrollment to late follow-up, up to 7 years",{"measure":14,"description":15,"timeFrame":12},"Number of participants who will experience bladder cancer recurrence","Bladder Cancer Recurrence",{"measure":17,"description":18,"timeFrame":12},"Number of participants who will die from all causes","All cause mortality after surgery",[20,23,26,29,32,35,38,41,44],{"measure":21,"description":22,"timeFrame":12},"Number of participants who will die from bladder cancer after Robotic Surgery","Robotic surgery specific impact on survival",{"measure":24,"description":25,"timeFrame":12},"Number of participants who will experience bladder cancer recurrence after Robotic Surgery","Robotic surgery specific impact on recurrence",{"measure":27,"description":28,"timeFrame":12},"Number of participants who will experience surgical complications after Robotic Surgery","Robotic surgery specific impact on surgical complications",{"measure":30,"description":31,"timeFrame":12},"Variation in Quality of Life questionnaire after Robotic Surgery","Robotic surgery specific impact on quality of life according to European Organisation for Research and Treatment of Cancer (EORTC) core quality of life questionnaire (QLQ-C30)",{"measure":33,"description":34,"timeFrame":12},"Variation in Quality of Life questionnaire according to Urinary diversions","Urinary diversion specific impact on quality of life according to European Organisation for Research and Treatment of Cancer (EORTC) core quality of life questionnaire (QLQ-C30)",{"measure":36,"description":37,"timeFrame":12},"Number of participants who will experience surgical complications according to Urinary diversions","Urinary diversion specific impact on surgical complications",{"measure":39,"description":40,"timeFrame":12},"Number of participants who will experience bladder cancer recurrence according to Urinary diversions","Urinary diversion specific impact on bladder cancer recurrence",{"measure":42,"description":43,"timeFrame":12},"Number of participants who will die from bladder cancer according to Urinary diversions","Urinary diversion specific impact on bladder cancer rmortality",{"measure":45,"description":46,"timeFrame":12},"Number of participants who will die from all causes according to Urinary diversions","Urinary diversion specific impact on all cause mortality after surgery",null,{"allocation":47,"interventionModel":47,"interventionModelDescription":47,"primaryPurpose":47,"observationalModel":49,"timePerspective":6,"maskingInfo":47},"COHORT","The study population is made up of patients who underwent radical cystectomy at AOU Careggi, SOD Robotic Urological Surgery, Minimally Invasive and Renal Transplantation.",[52],{"label":53,"type":47,"description":54,"interventionNames":55},"Radical Cystectomy","Patients who underwent radical cystectomy for bladder cancer in our centre",[56],"Procedure: Radical Cystectomy",[58],{"type":59,"name":53,"description":60,"armGroupLabels":61,"otherNames":47},"PROCEDURE","All the patients enrolled have undergone or will undergo radical cystectomy, with or without lymphadenectomy or urethrectomy All possibles urinary diversion are included, like ileal conduit, neobladder etc...",[53],[63,67,69],{"name":64,"affiliation":65,"role":66},"Arcangelo Sebastianelli, MD","Careggi Hospital, University of Florence","PRINCIPAL_INVESTIGATOR",{"name":68,"affiliation":5,"role":66},"Sergio Serni, Prof",{"name":70,"affiliation":5,"role":66},"Simone Morselli, MD",[72,76],{"name":70,"role":73,"phone":74,"phoneExt":47,"email":75},"CONTACT","3473050852","simone.morselli.89@gmail.com",{"name":77,"role":73,"phone":47,"phoneExt":47,"email":78},"Silvia Benemei, PhD","silvia.benemei@unifi.it",[80],{"facility":81,"status":82,"city":83,"state":84,"zip":85,"country":86,"countryCode":87,"cosmosGeoPoint":88,"geoPoint":93,"contacts":94},"Careggi University Hospital","RECRUITING","Florence","Tuscany","50134","Italy","IT",{"type":89,"coordinates":90},"Point",[91,92],11.24626,43.77925,{"lat":92,"lon":91},[95,97,99,100,103,104,106,107,109,111,113,115,117,119],{"name":70,"role":73,"phone":74,"phoneExt":47,"email":96},"simone.morselli@unifi.it",{"name":64,"role":73,"phone":47,"phoneExt":47,"email":98},"arcangelo.sebastianelli@gmail.com",{"name":68,"role":66,"phone":47,"phoneExt":47,"email":47},{"name":101,"role":102,"phone":47,"phoneExt":47,"email":47},"Mauro Gacci, MD","SUB_INVESTIGATOR",{"name":70,"role":66,"phone":47,"phoneExt":47,"email":47},{"name":105,"role":102,"phone":47,"phoneExt":47,"email":47},"Maria Rosaria Raspollini, MD",{"name":64,"role":66,"phone":47,"phoneExt":47,"email":47},{"name":108,"role":102,"phone":47,"phoneExt":47,"email":47},"Riccardo Campi, MD",{"name":110,"role":102,"phone":47,"phoneExt":47,"email":47},"Donata Villari, MD",{"name":112,"role":102,"phone":47,"phoneExt":47,"email":47},"Graziano Vignolini, MD",{"name":114,"role":102,"phone":47,"phoneExt":47,"email":47},"Saverio Giancane, MD",{"name":116,"role":102,"phone":47,"phoneExt":47,"email":47},"Pietro Spatafora, MD",{"name":118,"role":102,"phone":47,"phoneExt":47,"email":47},"Andrea Liaci, MD",{"name":120,"role":102,"phone":47,"phoneExt":47,"email":47},"Luca Gemma, MD",{"type":66,"investigatorFullName":122,"investigatorTitle":123,"investigatorAffiliation":5,"oldNameTitle":47,"oldOrganization":47},"Simone Morselli","PhD Student",[125],{"name":126,"class":6},"Azienda Ospedaliero-Universitaria Careggi","100431626",false,"NCT04900558","Robotic Radical Cystectomy Outcomes","Impact of Robotic Surgery on Post-operative Outcomes of Patients Who Underwent Radical Cystectomy","Inclusion Criteria:\n\n* Age major or equal 18 years\n* Patients who will undergo radical cystectomy\n* Consent to participate\n\nExclusion Criteria:\n\n* Absence of willingness to participate\n* Further refusal to participate to the study","ALL","18 Years",{"count":136,"type":137},500,"ESTIMATED","7 Years","OBSERVATIONAL","Currently, in the treatment of bladder cancer the use of robotics has entered in clinical practice, therefor robotic radical cystectomy with or without reconstruction is offered to patients during counseling procedures, if deemed appropriate and possible. The aim of the study is therefore the long-term evaluation of the peri-post-operative, oncological and functional results of patients undergoing radical cystectomy, both with an open and robotic approach. This study will thus help to clarify the actual impact of robotic surgery",[142,143,144,145,146],"Bladder Cancer","Muscle-Invasive Bladder Carcinoma","Oncology","Recurrence","Surgery",[148,53,149,150,142,151],"Cystectomy","Ileal Conduit","Neobladder","Muscle Invasive Bladder Cancer","2021-05-19",{"date":154,"type":155},"2021-05-25","ACTUAL",{"date":157,"type":155},"2021-04-29",{"date":159,"type":137},"2038-02-01",{"name":5,"class":6},1]